Annoroad , a Chinese gene - sequencing firm , has raised $ 105 m in a Series C funding round led by Ping An Ventures and Shenzhen GTJA Investment ##s . SoftBank China Venture Capital also invested in the round . Beijing - based Annoroad is known for its fertility and tumour test products , and is one of the largest genomics companies in China . The funds will be used to develop the company 's overseas market presence , improve its R&D efforts and hire further staff . Some funding will be used for its SolarGenomics subsidiary , which offers a cloud - based platform for the storage of data and research .
Annoroad, a Chinese gene-sequencing firm, has raised $105m in a series C funding round led by Ping An Ventures and Shenzhen GTJA Investment Group. SoftBank China Venture Capital also invested in the round. Beijing-based Annoroad is recognised for its fertility and tumour test products, and is one of the largest genomics companies in China. The funds will be used to develop the company's overseas business connections, improve its R&D efforts and hire further staff. Some funding will be used for its SolarGenomics subsidiary, which offers a cloud-based platform for the storage of bioinformatics and research.